The Centers for Disease Control and Prevention (CDC) is tracking an outbreak of monkeypox that has spread across several countries, including the United States. The CDC is urging healthcare providers in the United States to be alert for patients who have rash illnesses consistent with monkeypox.
NextGen Office EHR/PM urges clients to remain up to date on the latest information from the CDC on signs and symptoms, prevention, and treatment.
Monkeypox Vaccine Update
The American Medical Association (AMA) added two new CPT codes to describe the two smallpox and monkeypox virus products currently available for vaccines on Friday, July 29, 2022.
- 90622 describes the existing FDA-approved ACAM2000 vaccine manufactured by Sanofi Pasteur Biologics Co. for persons determined to be at high risk for smallpox infection.
- 90611 describes the FDA-approved JYNNEOS vaccine manufactured by Bavarian Nordic for prevention of smallpox and monkeypox disease in adults 18 years or older and at risk for infection.
Laboratory Test Code
The AMA added the new CPT code 87593 to describe molecular diagnostic testing that detects the nucleic signature of an orthopoxvirus, including the monkeypox virus.
Use E-visits to Avoid Potential Contagion Exposure
E-visits can play a key role in avoiding potential monkeypox contagion exposure in the office. Clients interested in learning about NextGen Office E-visits should reach out to their Account Manager or contact NextGen Office Client Support.
For information on telemedicine billing rules, see published Medicare Telehealth Guidance and Medicaid Telehealth Guidance from CMS.